{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:11:58Z","timestamp":1778490718377,"version":"3.51.4"},"reference-count":36,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The glyoxalase system, particularly glyoxalase-I (GLO-I), has been approved as a potential target for cancer treatment. In this study, a set of structurally diverse polyphenolic natural compounds were investigated as potential GLO-I inhibitors. Ellagic acid was found, computationally and experimentally, to be the most potent GLO-I inhibitor among the tested compounds which showed an\n                    <jats:italic>IC<\/jats:italic>\n                    <jats:sub>50<\/jats:sub>\n                    of 0.71 mmol L\n                    <jats:sup>\u22121<\/jats:sup>\n                    . Its binding to the GLO-I active site seemed to be mainly driven by ionic interaction\n                    <jats:italic>via<\/jats:italic>\n                    its ionized hydroxyl groups with the central Zn ion and Lys156, along with other numerous hydrogen bonding and hydrophobic interactions. Due to its unique and rigid skeleton, it can be utilized to search for other novel and potent GLO-I inhibitors\n                    <jats:italic>via<\/jats:italic>\n                    computational approaches such as pharmacophore modeling and similarity search methods. Moreover, an inspection of the docked poses of the tested compounds showed that chlorogenic acid and dihydrocaffeic acid could be considered as lead compounds worthy of further optimization.\n                  <\/jats:p>","DOI":"10.2478\/acph-2021-0005","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T09:15:14Z","timestamp":1599470114000},"page":"115-130","source":"Crossref","is-referenced-by-count":16,"title":["Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold"],"prefix":"10.2478","volume":"71","author":[{"given":"Nizar A.","family":"Al-Shar\u2019i","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy , Jordan University of Science and Technology , P.O. Box 3030 Irbid 22110 , Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qosay A.","family":"Al-Balas","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy , Jordan University of Science and Technology , P.O. Box 3030 Irbid 22110 , Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy , Jordan University of Science and Technology , P.O. Box 3030 Irbid 22110 , Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamam M.","family":"El-Elimat","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy , Jordan University of Science and Technology , P.O. Box 3030 Irbid 22110 , Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazi A.","family":"Aljabal","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy , Jordan University of Science and Technology , P.O. Box 3030 Irbid 22110 , Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar M.","family":"Almaaytah","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy , Jordan University of Science and Technology , P.O. Box 3030, Irbid 22110 , Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"2026051108214406134_j_acph-2021-0005_ref_001_w2aab3b7b9b1b6b1ab1ab1Aa","doi-asserted-by":"crossref","unstructured":"1. P. J. Thornalley, The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life, Biochem. J. 269 (1990) 1\u201311.","DOI":"10.1042\/bj2690001"},{"key":"2026051108214406134_j_acph-2021-0005_ref_002_w2aab3b7b9b1b6b1ab1ab2Aa","doi-asserted-by":"crossref","unstructured":"2. M. Sousa Silva, R. A. Gomes, A. E. N. Ferreira, A. P. Freire and C. Cordeiro, The glyoxalase pathway: the first hundred years\u2026 and beyond, Biochem. J. 453 (2013) 1\u201315; https:\/\/doi.org\/10.1042\/bj2012174310.1042\/BJ20121743","DOI":"10.1042\/BJ20121743"},{"key":"2026051108214406134_j_acph-2021-0005_ref_003_w2aab3b7b9b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. A. Rulli, L. Carli, R. Romani, T. Baroni, E. Giovannini, G. Rosi and V. Talesa, Expression of glyoxalase I and II in normal and breast cancer tissues, Breast Cancer Res. Treat. 66 (2001) 67\u201372; https:\/\/doi.org\/10.1023\/a:101063291912910.1023\/A:1010632919129","DOI":"10.1023\/A:1010632919129"},{"key":"2026051108214406134_j_acph-2021-0005_ref_004_w2aab3b7b9b1b6b1ab1ab4Aa","doi-asserted-by":"crossref","unstructured":"4. E. Mearini, R. Romani, L. Mearini, C. Antognelli, A. Zucchi, T. Baroni, M. Porena and V. N. Talesa, Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas, Eur. J. Cancer38 (2002) 1946\u20131950; https:\/\/doi.org\/10.1016\/S0959-8049(02)00236-810.1016\/S0959-8049(02)00236-8","DOI":"10.1016\/S0959-8049(02)00236-8"},{"key":"2026051108214406134_j_acph-2021-0005_ref_005_w2aab3b7b9b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. P. J. Thornalley, The glyoxalase system in health and disease, Mol. Aspects Med.14 (1993) 287\u2013371; https:\/\/doi.org\/10.1016\/0098-2997(93)90002-U10.1016\/0098-2997(93)90002-U","DOI":"10.1016\/0098-2997(93)90002-U"},{"key":"2026051108214406134_j_acph-2021-0005_ref_006_w2aab3b7b9b1b6b1ab1ab6Aa","doi-asserted-by":"crossref","unstructured":"6. Q. Al-Balas, M. Hassan, B. Al-Oudat, H. Alzoubi, N. Mhaidat and A. Almaaytah, Generation of the first structure-based pharmacophore model containing a selective \u201czinc binding group\u201d feature to identify potential glyoxalase-I inhibitors, Molecules17 (2012) 13740\u201313758; https:\/\/doi.org\/10.3390\/molecules17121374010.3390\/molecules171213740626817123174893","DOI":"10.3390\/molecules171213740"},{"key":"2026051108214406134_j_acph-2021-0005_ref_007_w2aab3b7b9b1b6b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"7. A. N. Al-Shar\u2019i, M. Hassan, Q. Al-Balas and A. Almaaytah, Identification of possible glyoxalase II inhibitors as anticancer agents by a customized 3D structure-based pharmacophore model, Jordan J. Pharm. Sci. 8 (2015) 83\u2013103.10.12816\/0025734","DOI":"10.12816\/0025734"},{"key":"2026051108214406134_j_acph-2021-0005_ref_008_w2aab3b7b9b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. A. D. Cameron, B. Olin, M. Ridderstr\u00f6m, B. Mannervik and T. A. Jones, Crystal structure of human glyoxalase I - evidence for gene duplication and 3D domain swapping, EMBO J. 16 (1997) 3386\u20133395; https:\/\/doi.org\/10.1093\/emboj\/16.12.338610.1093\/emboj\/16.12.338611699649218781","DOI":"10.1093\/emboj\/16.12.3386"},{"key":"2026051108214406134_j_acph-2021-0005_ref_009_w2aab3b7b9b1b6b1ab1ab9Aa","doi-asserted-by":"crossref","unstructured":"9. Q. A. Al-Balas, M. A. Hassan, N. A. Al-Shar\u2019i, N. M. Mhaidat, A. M. Almaaytah, F. M. Al-Mahasneh, and I. H. Isawi, Novel glyoxalase-I inhibitors possessing a \u201czinc-binding feature\u201d as potential anti-cancer agents, Drug Des. Dev. Ther.10 (2016) 2623\u20132629; https:\/\/doi.org\/10.2147\/DDDT.S11099710.2147\/DDDT.S110997499325727574401","DOI":"10.2147\/DDDT.S110997"},{"key":"2026051108214406134_j_acph-2021-0005_ref_010_w2aab3b7b9b1b6b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. Q. A. Al-Balas, A. M. Hassan, G. A. Al Jabal, N. A. Al-Shar\u2019i, A. M. Almaaytah and T. El-Elimat, Novel thiazole carboxylic acid derivatives possessing a \u201czinc binding feature\u201d as potential human glyoxalase-I inhibitors, Lett. Drug Des. Discov.14 (2017) 1324\u20131334; https:\/\/doi.org\/10.2174\/157018081466617030612095410.2174\/1570180814666170306120954","DOI":"10.2174\/1570180814666170306120954"},{"key":"2026051108214406134_j_acph-2021-0005_ref_011_w2aab3b7b9b1b6b1ab1ac11Aa","doi-asserted-by":"crossref","unstructured":"11. Q. A. Al-Balas, M. A. Hassan, N. A. Al-Shar\u2019i, T. El-Elimat and A. M. Almaaytah, Computational and experimental exploration of the structure\u2013activity relationships of flavonoids as potent glyoxalase-I inhibitors, Drug Dev. Res. 79 (2018) 58\u201369; https:\/\/doi.org\/10.1002\/ddr.2142110.1002\/ddr.2142129285772","DOI":"10.1002\/ddr.21421"},{"key":"2026051108214406134_j_acph-2021-0005_ref_012_w2aab3b7b9b1b6b1ab1ac12Aa","unstructured":"12. Q. Al-Balas, N. Al-Shar\u2019i, K. Banisalman, M. Hassan, G. A. Jabal and A. Almaaytah, Design, synthesis and biological evaluation of potential novel zinc binders targeting human glyoxalase-I; A validated target for cancer treatment, Jordan J. Pharm. Sci. 11 (2018) 25\u201337."},{"key":"2026051108214406134_j_acph-2021-0005_ref_013_w2aab3b7b9b1b6b1ab1ac13Aa","doi-asserted-by":"crossref","unstructured":"13. Q. A. Al-Balas, M. A. Hassan, N. A. Al-Shar\u2019i, G. A. Al Jabal and A. M. Almaaytah, Recent advances in glyoxalase-I inhibition, Mini-Rev. Med. Chem.19 (2019) 281\u2013291; https:\/\/doi.org\/10.2174\/138955751866618100914123110.2174\/138955751866618100914123130306863","DOI":"10.2174\/1389557518666181009141231"},{"key":"2026051108214406134_j_acph-2021-0005_ref_014_w2aab3b7b9b1b6b1ab1ac14Aa","doi-asserted-by":"crossref","unstructured":"14. N. A. Al-Shar\u2019i, Q. A. Al-Balas, R. A. Al-Waqfi, M. A. Hassan, A. E. Alkhalifa and N. M. Ayoub, Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based polypharmacophore modelling and molecular docking, J. Comput. Aid. Mol. Des. 33 (2019) 799\u2013815; https:\/\/doi.org\/10.1007\/s10822-019-00226-810.1007\/s10822-019-00226-831630312","DOI":"10.1007\/s10822-019-00226-8"},{"key":"2026051108214406134_j_acph-2021-0005_ref_015_w2aab3b7b9b1b6b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. N. A. Al-Shar\u2019i, E. K. Al-Rousan, L. I. Fakhouri, Q. A. Al-Balas and M. A. Hassan, Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking, Med. Chem. Res. 29 (2020) 356\u2013376; https:\/\/doi.org\/10.1007\/s00044-019-02486-310.1007\/s00044-019-02486-3","DOI":"10.1007\/s00044-019-02486-3"},{"key":"2026051108214406134_j_acph-2021-0005_ref_016_w2aab3b7b9b1b6b1ab1ac16Aa","doi-asserted-by":"crossref","unstructured":"16. B. R. Brooks, C. L. Brooks, A. D. MacKerell, L. Nilsson, R. J. Petrella, B. Roux, Y. Won, G. Archontis, C. Bartels, S. Boresch, A. Caflisch, L. Caves, Q. Cui, A. R. Dinner, M. Feig, S. Fischer, J. Gao, M. Hodoscek, W. Im, K. Kuczera, T. Lazaridis, J. Ma, V. Ovchinnikov, E. Paci, R. W. Pastor, C. B. Post, J. Z. Pu, M. Schaefer, B. Tidor, R. M. Venable, H. L. Woodcock, X. Wu, W. Yang, D. M. York and M. Karplus, CHARMM: The biomolecular simulation program, J. Comput. Chem. 30 (2009) 1545\u20131614; https:\/\/doi.org\/10.1002\/jcc.2128710.1002\/jcc.21287281066119444816","DOI":"10.1002\/jcc.21287"},{"key":"2026051108214406134_j_acph-2021-0005_ref_017_w2aab3b7b9b1b6b1ab1ac17Aa","doi-asserted-by":"crossref","unstructured":"17. M. S. Lee, M. Feig, F. R. Salsbury and C. L. Brooks, New analytic approximation to the standard molecular volume definition and its application to generalized Born calculations, J. Comput. Chem. 24 (2003) 1348\u20131356; https:\/\/doi.org\/doi:10.1002\/jcc.1027210.1002\/jcc.1027212827676","DOI":"10.1002\/jcc.10272"},{"key":"2026051108214406134_j_acph-2021-0005_ref_018_w2aab3b7b9b1b6b1ab1ac18Aa","doi-asserted-by":"crossref","unstructured":"18. P. Mark and L. Nilsson, Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K, J. Phys. Chem. A105 (2001) 9954\u20139960; https:\/\/doi.org\/10.1021\/jp003020w10.1021\/jp003020w","DOI":"10.1021\/jp003020w"},{"key":"2026051108214406134_j_acph-2021-0005_ref_019_w2aab3b7b9b1b6b1ab1ac19Aa","doi-asserted-by":"crossref","unstructured":"19. I. \u0160tich, R. Car, M. Parrinell and S. Baroni, Conjugate gradient minimization of the energy functional: A new method for electronic structure calculation, Phys. Rev. B39 (1989) 4997\u20135004; https:\/\/doi.org\/10.1103\/PhysRevB.39.499710.1103\/PhysRevB.39.4997","DOI":"10.1103\/PhysRevB.39.4997"},{"key":"2026051108214406134_j_acph-2021-0005_ref_020_w2aab3b7b9b1b6b1ab1ac20Aa","doi-asserted-by":"crossref","unstructured":"20. G. Wu, D. H. Robertson, C. L. Brooks and M. Vieth, Detailed analysis of grid-based molecular docking: A case study of CDOCKER\u2014A CHARMm-based MD docking algorithm, J. Comput. Chem. 24 (2003) 1549\u20131562; https:\/\/doi.org\/10.1002\/jcc.1030610.1002\/jcc.1030612925999","DOI":"10.1002\/jcc.10306"},{"key":"2026051108214406134_j_acph-2021-0005_ref_021_w2aab3b7b9b1b6b1ab1ac21Aa","doi-asserted-by":"crossref","unstructured":"21. R. Takasawa, H. Akahane, H. Tanaka, N. Shimada, T. Yamamoto, H. Uchida-Maruki, M. Sai, A. Yoshimori and S.-i. Tanuma, Piceatannol, a natural trans-stilbene compound, inhibits human glyoxalase I, Bioorg. Med. Chem. Lett.27 (2017) 1169\u20131174; https:\/\/doi.org\/10.1016\/j.bmcl.2017.01.07010.1016\/j.bmcl.2017.01.07028169168","DOI":"10.1016\/j.bmcl.2017.01.070"},{"key":"2026051108214406134_j_acph-2021-0005_ref_022_w2aab3b7b9b1b6b1ab1ac22Aa","doi-asserted-by":"crossref","unstructured":"22. A. Z. Simi\u0107, T. \u017d. Verbi\u0107, M. N. Senti\u0107, M. P. Voji\u0107, I. O. Jurani\u0107 and D. D. Manojlovi\u0107, Study of ellagic acid electro-oxidation mechanism, Monatsh. Chem. Chem. Mon. 144 (2013) 121\u2013128; https:\/\/doi.org\/10.1007\/s00706-012-0856-810.1007\/s00706-012-0856-8","DOI":"10.1007\/s00706-012-0856-8"},{"key":"2026051108214406134_j_acph-2021-0005_ref_023_w2aab3b7b9b1b6b1ab1ac23Aa","doi-asserted-by":"crossref","unstructured":"23. Z. Markovi\u0107, D. Milenkovi\u0107, J. \u0110orovi\u0107, J. M. Dimitri\u0107 Markovi\u0107, B. Lu\u010di\u0107 and D. Ami\u0107, A DFT and PM6 study of free radical scavenging activity of ellagic acid, Monatsh. Chem. Chem. Mon.144 (2013) 803\u2013812; https:\/\/doi.org\/10.1007\/s00706-013-0949-z10.1007\/s00706-013-0949-z","DOI":"10.1007\/s00706-013-0949-z"},{"key":"2026051108214406134_j_acph-2021-0005_ref_024_w2aab3b7b9b1b6b1ab1ac24Aa","doi-asserted-by":"crossref","unstructured":"24. Y. Yao, G. Lin, Y. Xie, P. Ma, G. Li, Q. Meng and T. Wu, Preformulation studies of myricetin: a natural antioxidant flavonoid, Pharmazie69 (2014) 19\u201326.","DOI":"10.31083\/ph.2014.3076"},{"key":"2026051108214406134_j_acph-2021-0005_ref_025_w2aab3b7b9b1b6b1ab1ac25Aa","doi-asserted-by":"crossref","unstructured":"25. R. S. Mulliken, Electronic population analysis on LCAO\u2013MO molecular wave functions. I, J. Chem. Phys. 23 (1955) 1833\u20131840; https:\/\/doi.org\/10.1063\/1.174058810.1063\/1.1740588","DOI":"10.1063\/1.1740588"},{"key":"2026051108214406134_j_acph-2021-0005_ref_026_w2aab3b7b9b1b6b1ab1ac26Aa","doi-asserted-by":"crossref","unstructured":"26. F. L. Hirshfeld, Bonded-atom fragments for describing molecular charge densities, Theor. Chim. Acta44 (1977) 129\u2013138; https:\/\/doi.org\/10.1007\/bf0054909610.1007\/BF00549096","DOI":"10.1007\/BF00549096"},{"key":"2026051108214406134_j_acph-2021-0005_ref_027_w2aab3b7b9b1b6b1ab1ac27Aa","doi-asserted-by":"crossref","unstructured":"27. H. F. P. Martins, J. P. Leal, M. T. Fernandez, V. H. C. Lopes and M. N. D. S. Cordeiro, Toward the prediction of the activity of antioxidants: experimental and theoretical study of the gas-phase acidities of flavonoids, J. Am. Soc. Mass Spectrom. 15 (2004) 848\u2013861; https:\/\/doi.org\/10.1016\/j.jasms.2004.02.00710.1016\/j.jasms.2004.02.007","DOI":"10.1016\/j.jasms.2004.02.007"},{"key":"2026051108214406134_j_acph-2021-0005_ref_028_w2aab3b7b9b1b6b1ab1ac28Aa","doi-asserted-by":"crossref","unstructured":"28. G. G\u00fcnther, E. Berr\u00edos, N. Pizarro, K. Vald\u00e9s, G. Montero, F. Arriagada and J. Morales, Flavonoids in microheterogeneous media, relationship between their relative location and their reactivity towards singlet oxygen, PLoS ONE10 (2015) e0129749; https:\/\/doi.org\/10.1371\/journal.pone.012974910.1371\/journal.pone.0129749","DOI":"10.1371\/journal.pone.0129749"},{"key":"2026051108214406134_j_acph-2021-0005_ref_029_w2aab3b7b9b1b6b1ab1ac29Aa","doi-asserted-by":"crossref","unstructured":"29. B. Delley, An all-electron numerical method for solving the local density functional for polyatomic molecules, J. Chem. Phys.92 (1990) 508\u2013517; https:\/\/doi.org\/10.1063\/1.45845210.1063\/1.458452","DOI":"10.1063\/1.458452"},{"key":"2026051108214406134_j_acph-2021-0005_ref_030_w2aab3b7b9b1b6b1ab1ac30Aa","doi-asserted-by":"crossref","unstructured":"30. T. Lengauer and M. Rarey, Computational methods for biomolecular docking, Curr. Opin. Struct. Biol.6 (1996) 402\u2013406; https:\/\/doi.org\/10.1016\/S0959-440X(96)80061-310.1016\/S0959-440X(96)80061-3","DOI":"10.1016\/S0959-440X(96)80061-3"},{"key":"2026051108214406134_j_acph-2021-0005_ref_031_w2aab3b7b9b1b6b1ab1ac31Aa","doi-asserted-by":"crossref","unstructured":"31. P. Ferrara, H. Gohlke, D. J. Price, G. Klebe and C. L. Brooks, Assessing Scoring functions for protein-ligand interactions, J. Med. Chem.47 (2004) 3032\u20133047; https:\/\/doi.org\/10.1021\/jm030489h10.1021\/jm030489h15163185","DOI":"10.1021\/jm030489h"},{"key":"2026051108214406134_j_acph-2021-0005_ref_032_w2aab3b7b9b1b6b1ab1ac32Aa","doi-asserted-by":"crossref","unstructured":"32. S. Genheden and U. Ryde, The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities, Expert Opin. Drug Discov.10 (2015) 449\u2013461; https:\/\/doi.org\/10.1517\/17460441.2015.103293610.1517\/17460441.2015.1032936448760625835573","DOI":"10.1517\/17460441.2015.1032936"},{"key":"2026051108214406134_j_acph-2021-0005_ref_033_w2aab3b7b9b1b6b1ab1ac33Aa","doi-asserted-by":"crossref","unstructured":"33. S. Mati\u0107, M. Jadrijevi\u0107-Mladar Taka\u010d, M. Barbari\u0107, B. Lu\u010di\u0107, K. Gall Tro\u0161elj and V. Stepani\u0107, The influence of in vivo metabolic modifications on ADMET properties of green tea catechins \u2013 In silico analysis, J. Pharm. Sci. 107 (2018) 2957\u20132964; https:\/\/doi.org\/10.1016\/j.xphs.2018.07.02610.1016\/j.xphs.2018.07.02630077700","DOI":"10.1016\/j.xphs.2018.07.026"},{"key":"2026051108214406134_j_acph-2021-0005_ref_034_w2aab3b7b9b1b6b1ab1ac34Aa","doi-asserted-by":"crossref","unstructured":"34. N. J. Cox, Speaking stata: Correlation with confidence, or Fisher\u2019s z revisited, Stata J. 8 (2008) 413\u2013439; https:\/\/ageconsearch.umn.edu\/record\/122603","DOI":"10.1177\/1536867X0800800307"},{"key":"2026051108214406134_j_acph-2021-0005_ref_035_w2aab3b7b9b1b6b1ab1ac35Aa","doi-asserted-by":"crossref","unstructured":"35. D. A. Vattem and K. Shetty, Biological functionality of ellagic acid: a review, J. Food Biochem. 29 (2005) 234\u2013266; https:\/\/doi.org\/10.1111\/j.1745-4514.2005.00031.x10.1111\/j.1745-4514.2005.00031.x","DOI":"10.1111\/j.1745-4514.2005.00031.x"},{"key":"2026051108214406134_j_acph-2021-0005_ref_036_w2aab3b7b9b1b6b1ab1ac36Aa","doi-asserted-by":"crossref","unstructured":"36. J. M. Landete, Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health, Food Res. Int.44 (2011) 1150\u20131160; https:\/\/doi.org\/10.1016\/j.foodres.2011.04.02710.1016\/j.foodres.2011.04.027","DOI":"10.1016\/j.foodres.2011.04.027"}],"container-title":["Acta Pharmaceutica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/acph\/71\/1\/article-p115.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/acph-2021-0005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:57:51Z","timestamp":1778489871000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/acph-2021-0005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,7,20]]},"published-print":{"date-parts":[[2021,3,1]]}},"alternative-id":["10.2478\/acph-2021-0005"],"URL":"https:\/\/doi.org\/10.2478\/acph-2021-0005","relation":{},"ISSN":["1846-9558"],"issn-type":[{"value":"1846-9558","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]}}}